预测原发性硬化性胆管炎患者的胆管癌：血清学标志物CA 19-9分析 - Suppr | 超能文献

Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis: an analysis of the serological marker CA 19-9.

作者信息

Rogers S A, Podolsky D K

机构信息

Gastrointestinal Unit, Massachusetts General Hospital, Boston 02114.

出版信息

Hepatology. 1994 Feb;19(2):543-5. doi: 10.1002/hep.1840190239.

DOI:10.1002/hep.1840190239

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis: an analysis of the serological marker CA 19-9.预测原发性硬化性胆管炎患者的胆管癌：血清学标志物CA 19-9分析

Hepatology. 1994 Feb;19(2):543-5. doi: 10.1002/hep.1840190239.

2

Cholangioscopy to screen for cholangiocarcinoma in primary sclerosing cholangitis.胆管镜检查用于在原发性硬化性胆管炎中筛查胆管癌。

Liver Transpl. 2001 Apr;7(4):380. doi: 10.1002/lt.500070417.

3

Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen?原发性硬化性胆管炎中的胆管癌：哪些人有风险以及我们如何进行筛查？

Hepatology. 2000 Jan;31(1):247-8. doi: 10.1002/hep.510310137.

4

Diagnosing cholangiocarcinoma in primary sclerosing cholangitis: an "evidence based radiology" review.原发性硬化性胆管炎中胆管癌的诊断：一项“循证放射学”综述

Abdom Imaging. 2008 Jan-Feb;33(1):14-7. doi: 10.1007/s00261-007-9314-1.

5

Bile duct brushings for the early detection of cholangiocarcinoma.用于胆管癌早期检测的胆管刷检

J Clin Gastroenterol. 2006 Apr;40(4):279-80. doi: 10.1097/01.mcg.0000210107.05113.29.

6

Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.原发性硬化性胆管炎中的肝胆及肝外恶性肿瘤

Best Pract Res Clin Gastroenterol. 2001 Aug;15(4):643-56. doi: 10.1053/bega.2001.0210.

7

Cholangiocarcinoma in a 17-year-old boy with primary sclerosing cholangitis and inflammatory bowel disease.一名患有原发性硬化性胆管炎和炎症性肠病的17岁男孩患胆管癌。

J Pediatr Gastroenterol Nutr. 2011 May;52(5):617-20. doi: 10.1097/MPG.0b013e3181f9a5d2.

8

A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.一项关于用于检测原发性硬化性胆管炎患者胆管癌的血清肿瘤标志物的3年前瞻性研究。

J Hepatol. 1999 Apr;30(4):669-73. doi: 10.1016/s0168-8278(99)80198-6.

9

Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.原发性硬化性胆管炎和胆管癌：发病机制和诊断模式。

Dig Dis. 2013;31(1):118-25. doi: 10.1159/000347206. Epub 2013 Jun 17.

10

Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis.原发性硬化性胆管炎患者的胆管癌监测建议

Clin Liver Dis. 2024 Feb;28(1):183-192. doi: 10.1016/j.cld.2023.07.010. Epub 2023 Aug 28.

引用本文的文献

1

The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis.血清CA 19-9在预测原发性硬化性胆管炎患者胆管癌中的价值。

Dig Dis Sci. 2005 Sep;50(9):1734-40. doi: 10.1007/s10620-005-2927-8.

2

Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker.胆管癌患者血清白细胞介素-6显著升高：作为临床标志物效用的验证

Ann Surg. 1998 Mar;227(3):398-404. doi: 10.1097/00000658-199803000-00012.